| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Applied Physiology, Vol 75, Issue 1 114-120, Copyright © 1993 by American Physiological Society
ARTICLES |
H. L. Collins and S. E. DiCarlo
Department of Physiology, Northeastern Ohio Universities College of Medicine, Rootstown 44272.
The influence of cardiac afferents on the muscle metaboreflex was examined in 16 rats instrumented with a Silastic-tipped catheter in the pericardial space and right atrium, Doppler ultrasonic flow probe and a pneumatic vascular occluder around the terminal aorta, and a Teflon catheter in the thoracic aorta. In protocol I (cardiac efferent and afferent blockade), the muscle metaboreflex was examined under three experimental conditions: 1) control, 2) cardiac autonomic efferent blockade [intrapericardial methylscopolamine (10 micrograms/kg) and propranolol (50 micrograms/kg)], and 3) combined cardiac autonomic efferent and afferent blockade (intrapericardial procainamide, 2%). In protocol II (blood volume expansion), the muscle metaboreflex was examined before and after 15% blood volume expansion. Mild treadmill exercise (9 m/min, 10% grade) increased heart rate (71 +/- 9.4 beats/min), mean arterial pressure (12 +/- 2.0 mmHg), and terminal aortic blood flow velocity (6 +/- 1.0 kHz). During exercise, a reduction of terminal aortic blood flow velocity (10.5 +/- 1.1%) reduced mixed venous PO2 18 +/- 6%. The gain of the muscle metaboreflex in the control condition was 14.6 +/- 2.9 mmHg/kHz. Efferent blockade reduced the gain 51 +/- 7%. However, combined cardiac efferent and afferent blockade increased the gain 207 +/- 64% above the efferent blocked condition and restored the gain to levels above those obtained in the control condition (18.3 +/- 4.6 mmHg/kHz). In addition, 15% blood volume expansion reduced the gain of the muscle metaboreflex regulation of mean arterial pressure and heart rate (44 +/- 9.5% and 41 +/- 12.0%, respectively). Thus cardiac afferents tonically inhibit the pressor response to a reduction in terminal aortic blood flow velocity during exercise.
This article has been cited by other articles:
|
|
 |
|
  T. Nishiyasu, M. Ichinose, W. G. Guntheroth, and H. L. Collins Comment on Point:Counterpoint "The muscle metaboreflex does/does not restore blood flow to contracting muscles" J Appl Physiol, February 1, 2006; 100(2): 750 - 751. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Hammond, R. A. Augustyniak, N. F. Rossi, P. C. Churchill, K. Lapanowski, and D. S. O'Leary Heart failure alters the strength and mechanisms of the muscle metaboreflex Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H818 - H828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Augustyniak, E. J. Ansorge, and D. S. O'Leary Muscle metaboreflex control of cardiac output and peripheral vasoconstriction exhibit different latencies Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H530 - H537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. O'Leary, R. A. Augustyniak, E. J. Ansorge, and H. L. Collins Muscle metaboreflex improves O2 delivery to ischemic active skeletal muscle Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1399 - H1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sheriff, R. A. Augustyniak, and D. S. O'Leary Muscle chemoreflex-induced increases in right atrial pressure Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H767 - H775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. O'Leary and R. A. Augustyniak Muscle metaboreflex increases ventricular performance in conscious dogs Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H220 - H224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. O'Hagan, S. M. Casey, and P. S. Clifford Muscle chemoreflex increases renal sympathetic nerve activity during exercise J Appl Physiol, June 1, 1997; 82(6): 1818 - 1825. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
